Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons

Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2015-11, Vol.273, p.243-252
Hauptverfasser: Caudal, D., Alvarsson, A., Björklund, A., Svenningsson, P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 252
container_issue
container_start_page 243
container_title Experimental neurology
container_volume 273
creator Caudal, D.
Alvarsson, A.
Björklund, A.
Svenningsson, P.
description Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity. •α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.
doi_str_mv 10.1016/j.expneurol.2015.09.002
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_510760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488615300844</els_id><sourcerecordid>1733196331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</originalsourceid><addsrcrecordid>eNqFkc2O0zAUhSMEYsrAK0CWbBKuf-LUy2r4lSqxAbaWY98w7iR2sJMOfSxehGfCnZbuEAvb11fn3GP5K4pXBGoCRLzZ1fhz8rjEMNQUSFODrAHoo2JFQEJFOYPHxQqA8Iqv1-KqeJbSDgAkp-3T4ooKJhiXzaq4f4tTxJTcHqvB3WE53aIP82HC0nm7GLRldyg3m2_ViNbpOd_DHmNOf3AFX4a-vF1G7cvfv6p08IsZ0PlsLkdnu6hzYcOkR-cxfnemfHi0T8-LJ70eEr44n9fF1_fvvtx8rLafP3y62Wwrw9v1XLV931DJOyF6YjURvRFWcmBIsJNMNJrJliEyLRgwSjVwQZCu0QjEpmENuy6q09x0j9PSqSm6UceDCtqpc-suV6gaAq2ArN_-Uz8sU15dXkcDkbRFY3tFDRDFLZOqA26UaQ3NLdA9Z3nc69O4KYYfC6ZZjS4ZHAbtMSxJkZYxIkXesrQ9SU0MKUXsL9kE1BG62qkLdHWErkCqDD07X55Dli5Tuvj-Us6CzUmA-af3DqNKxqHPcF1EMysb3H9D_gABN8XC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1733196331</pqid></control><display><type>article</type><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</creator><creatorcontrib>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</creatorcontrib><description>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity. •α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2015.09.002</identifier><identifier>PMID: 26363495</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenocorticotropic Hormone - blood ; Alpha-synuclein ; alpha-Synuclein - genetics ; alpha-Synuclein - metabolism ; Animals ; Anxiety ; Basic Medicine ; Corticosterone ; Corticosterone - blood ; Dependovirus - genetics ; Depression ; Depression - blood ; Depression - etiology ; Depression - genetics ; Depression - pathology ; Disease Models, Animal ; Dopaminergic Neurons - pathology ; Female ; Food Preferences - psychology ; Gene Expression Regulation - genetics ; Humans ; Longitudinal Studies ; Maze Learning - physiology ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Mesencephalon - pathology ; Neurosciences ; Neurovetenskaper ; Parkinson disease ; Phenotype ; Psychomotor Performance - physiology ; Rats ; Rats, Sprague-Dawley ; Rats, Transgenic ; Stress, Psychological - complications ; Swimming - psychology ; Time Factors</subject><ispartof>Experimental neurology, 2015-11, Vol.273, p.243-252</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</citedby><cites>FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.expneurol.2015.09.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26363495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/8042481$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:132462383$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Caudal, D.</creatorcontrib><creatorcontrib>Alvarsson, A.</creatorcontrib><creatorcontrib>Björklund, A.</creatorcontrib><creatorcontrib>Svenningsson, P.</creatorcontrib><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity. •α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</description><subject>Adrenocorticotropic Hormone - blood</subject><subject>Alpha-synuclein</subject><subject>alpha-Synuclein - genetics</subject><subject>alpha-Synuclein - metabolism</subject><subject>Animals</subject><subject>Anxiety</subject><subject>Basic Medicine</subject><subject>Corticosterone</subject><subject>Corticosterone - blood</subject><subject>Dependovirus - genetics</subject><subject>Depression</subject><subject>Depression - blood</subject><subject>Depression - etiology</subject><subject>Depression - genetics</subject><subject>Depression - pathology</subject><subject>Disease Models, Animal</subject><subject>Dopaminergic Neurons - pathology</subject><subject>Female</subject><subject>Food Preferences - psychology</subject><subject>Gene Expression Regulation - genetics</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Maze Learning - physiology</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Mesencephalon - pathology</subject><subject>Neurosciences</subject><subject>Neurovetenskaper</subject><subject>Parkinson disease</subject><subject>Phenotype</subject><subject>Psychomotor Performance - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rats, Transgenic</subject><subject>Stress, Psychological - complications</subject><subject>Swimming - psychology</subject><subject>Time Factors</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2O0zAUhSMEYsrAK0CWbBKuf-LUy2r4lSqxAbaWY98w7iR2sJMOfSxehGfCnZbuEAvb11fn3GP5K4pXBGoCRLzZ1fhz8rjEMNQUSFODrAHoo2JFQEJFOYPHxQqA8Iqv1-KqeJbSDgAkp-3T4ooKJhiXzaq4f4tTxJTcHqvB3WE53aIP82HC0nm7GLRldyg3m2_ViNbpOd_DHmNOf3AFX4a-vF1G7cvfv6p08IsZ0PlsLkdnu6hzYcOkR-cxfnemfHi0T8-LJ70eEr44n9fF1_fvvtx8rLafP3y62Wwrw9v1XLV931DJOyF6YjURvRFWcmBIsJNMNJrJliEyLRgwSjVwQZCu0QjEpmENuy6q09x0j9PSqSm6UceDCtqpc-suV6gaAq2ArN_-Uz8sU15dXkcDkbRFY3tFDRDFLZOqA26UaQ3NLdA9Z3nc69O4KYYfC6ZZjS4ZHAbtMSxJkZYxIkXesrQ9SU0MKUXsL9kE1BG62qkLdHWErkCqDD07X55Dli5Tuvj-Us6CzUmA-af3DqNKxqHPcF1EMysb3H9D_gABN8XC</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Caudal, D.</creator><creator>Alvarsson, A.</creator><creator>Björklund, A.</creator><creator>Svenningsson, P.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope></search><sort><creationdate>20151101</creationdate><title>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</title><author>Caudal, D. ; Alvarsson, A. ; Björklund, A. ; Svenningsson, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-7ff5294b66f1da16fc6d9403e1eb9365a3973ee3a630322a0461e28ec6ee55353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adrenocorticotropic Hormone - blood</topic><topic>Alpha-synuclein</topic><topic>alpha-Synuclein - genetics</topic><topic>alpha-Synuclein - metabolism</topic><topic>Animals</topic><topic>Anxiety</topic><topic>Basic Medicine</topic><topic>Corticosterone</topic><topic>Corticosterone - blood</topic><topic>Dependovirus - genetics</topic><topic>Depression</topic><topic>Depression - blood</topic><topic>Depression - etiology</topic><topic>Depression - genetics</topic><topic>Depression - pathology</topic><topic>Disease Models, Animal</topic><topic>Dopaminergic Neurons - pathology</topic><topic>Female</topic><topic>Food Preferences - psychology</topic><topic>Gene Expression Regulation - genetics</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Maze Learning - physiology</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Mesencephalon - pathology</topic><topic>Neurosciences</topic><topic>Neurovetenskaper</topic><topic>Parkinson disease</topic><topic>Phenotype</topic><topic>Psychomotor Performance - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rats, Transgenic</topic><topic>Stress, Psychological - complications</topic><topic>Swimming - psychology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caudal, D.</creatorcontrib><creatorcontrib>Alvarsson, A.</creatorcontrib><creatorcontrib>Björklund, A.</creatorcontrib><creatorcontrib>Svenningsson, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caudal, D.</au><au>Alvarsson, A.</au><au>Björklund, A.</au><au>Svenningsson, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>273</volume><spage>243</spage><epage>252</epage><pages>243-252</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><abstract>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of nigral dopaminergic neurons and by the presence of aggregates containing α-synuclein called Lewy bodies. Viral vector-induced overexpression of α-synuclein in dopaminergic neurons represents a model of PD which recapitulates disease progression better than commonly used neurotoxin models. Previous studies using this model have reported motor and cognitive impairments, whereas depression, mood and anxiety phenotypes are less described. To investigate these psychiatric phenotypes, Sprague–Dawley rats received bilateral injections of a recombinant adeno-associated virus (AAV) vector expressing human α-synuclein or GFP into the substantia nigra pars compacta. Behavior was assessed at two timepoints: 3 and 8weeks post-injection. We report that nigral α-synuclein overexpression led to a pronounced nigral dopaminergic cell loss accompanied by a smaller cell loss in the ventral tegmental area, and to a decreased striatal density of dopaminergic fibers. The AAV-α-synuclein group exhibited modest, but significant motor impairments 8weeks after vector administration. The AAV-α-synuclein group displayed depressive-like behavior in the forced swim test after 3weeks, and reduced sucrose preference at week 8. At both timepoints, overexpression of α-synuclein was linked to a hyperactive hypothalamic–pituitary–adrenal (HPA) axis regulation of corticosterone. The depressive-like phenotype was also correlated with decreased nigral brain-derived neurotrophic factor and spinophilin levels, and with decreased striatal levels of the activity-regulated cytoskeleton-associated protein. This study demonstrates that AAV-mediated α-synuclein overexpression in dopamine neurons is not only useful to model motor impairments of PD, but also depression. This study also provides evidence that depression in experimental Parkinsonism is correlated to dysregulation of the HPA axis and to alterations in proteins involved in synaptic plasticity. •α-Synuclein overexpression in midbrain dopaminergic neurons induces a depressive-like phenotype•HPA axis hyperactivation is induced by α-synuclein overexpression in midbrain dopaminergic neurons•α-Synuclein overexpression is linked to decreased nigral BDNF and spinophilin levels, and decreased striatal Arc levels.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26363495</pmid><doi>10.1016/j.expneurol.2015.09.002</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2015-11, Vol.273, p.243-252
issn 0014-4886
1090-2430
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_510760
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenocorticotropic Hormone - blood
Alpha-synuclein
alpha-Synuclein - genetics
alpha-Synuclein - metabolism
Animals
Anxiety
Basic Medicine
Corticosterone
Corticosterone - blood
Dependovirus - genetics
Depression
Depression - blood
Depression - etiology
Depression - genetics
Depression - pathology
Disease Models, Animal
Dopaminergic Neurons - pathology
Female
Food Preferences - psychology
Gene Expression Regulation - genetics
Humans
Longitudinal Studies
Maze Learning - physiology
Medical and Health Sciences
Medicin och hälsovetenskap
Medicinska och farmaceutiska grundvetenskaper
Mesencephalon - pathology
Neurosciences
Neurovetenskaper
Parkinson disease
Phenotype
Psychomotor Performance - physiology
Rats
Rats, Sprague-Dawley
Rats, Transgenic
Stress, Psychological - complications
Swimming - psychology
Time Factors
title Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T07%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depressive-like%20phenotype%20induced%20by%20AAV-mediated%20overexpression%20of%20human%20%CE%B1-synuclein%20in%20midbrain%20dopaminergic%20neurons&rft.jtitle=Experimental%20neurology&rft.au=Caudal,%20D.&rft.date=2015-11-01&rft.volume=273&rft.spage=243&rft.epage=252&rft.pages=243-252&rft.issn=0014-4886&rft.eissn=1090-2430&rft_id=info:doi/10.1016/j.expneurol.2015.09.002&rft_dat=%3Cproquest_swepu%3E1733196331%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1733196331&rft_id=info:pmid/26363495&rft_els_id=S0014488615300844&rfr_iscdi=true